查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591897

人类生殖技术市场：按类型、应用和最终用户划分 - 全球预测 2025-2030

Human Reproductive Technologies Market by Type (Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination), Application (Fertility Preservation, Genetic Screening, Infertility Treatment), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人类生殖技术市场价值为298.4亿美元，预计到2024年将达到318.2亿美元，复合年增长率为6.66%，到2030年将达到468.9亿美元。

人类生殖技术是旨在透过医学和科学干预辅助人类生殖的多种治疗方法和技术的集合。此范围包括体外受精 (IVF)、人工授精、促排卵药物、代孕、新基因组技术等。这些技术的需求主要是由于延迟分娩、生活方式因素和某些医疗状况导致的不孕症盛行率不断增加而推动的。从应用来看，广泛应用于生育诊所、医院、医疗研究机构等。最终用途包括希望生育的个别夫妻、同性伴侣和寻求辅助生殖的单亲父母。

主要市场统计
基准年[2023] 298.4亿美元
预测年份 [2024] 318.2亿美元
预测年份 [2030] 468.9亿美元
复合年增长率（%） 6.66%

人们对生殖技术的认识和接受度不断提高、医学科学的进步以及政府对生育旅游的支持性监管对市场产生了重大影响。此外，新兴国家可支配收入的增加和医疗基础设施的改善正在推动需求。然而，它也存在一些局限性，例如治疗费用上涨、伦理和法律问题以及可能给患者带来的心理压力。挑战包括影响技术采用的社会偏见和地区不同的法律体制。

潜在的成长机会在于技术进步，例如开发负担得起且易于获得的治疗方法、将生殖技术与个人遗传特征相匹配的个人化医疗以及有效预测治疗结果的人工智慧。对于希望利用这些机会的公司来说，投资研发以创建创新的生育解决方案、与医疗保健提供者建立伙伴关係以提供更广泛的服务以及支持可及性和保险政策宣传可能是一个战略步骤。创新热点包括非侵入性不孕症诊断、胚胎和配子冷冻保存以及用于患者参与和教育的行动医疗应用程式。该市场的特点是技术快速进步、竞争日益激烈，以及生物技术公司、製药公司和医疗保健行业之间的潜在合作，以有效解决未满足的需求，同时应对道德和监管环境。

市场动态：揭示快速发展的人类生殖技术市场的关键市场洞察

供需的动态交互作用正在改变人类生殖技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 生活方式的改变以及不孕症和不孕症相关疾病盛行率的上升
    • 旨在治疗不孕症的医疗旅游增加
    • 提高对不孕症治疗的认识与接受度
  • 市场限制因素
    • 不孕症治疗的费用高且保险范围有限
  • 市场机会
    • 人类生殖技术的进步和创新可实现更有效的治疗
    • 生殖技术创新的专利和版权
  • 市场挑战
    • 有限的成功率和相关的健康风险

波特五力：驾驭人类生殖科技市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对人类生殖技术市场的影响

外部宏观环境因素在塑造人类生殖技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人类生殖技术市场的竞争格局

对人类生殖技术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵人类生殖技术市场供应商的绩效评估

FPNV 定位矩阵是评估人类生殖技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，以规划人类生殖技术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人类生殖技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活方式的改变以及不孕症和不孕症相关疾病的增加
      • 以不孕症治疗为重点的医疗旅游增加
      • 提高对不孕症治疗的认识与接受度
    • 抑制因素
      • 不孕症治疗费用高且保险范围有限
    • 机会
      • 人类生殖技术的进步和创新可实现更有效的治疗
      • 与生殖技术创新相关的专利和版权
    • 任务
      • 有限的成功率和相关的健康风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人类生殖科技市场：依类型

  • 辅助生殖技术
  • 体外受精
  • 子宫内人工授精
  • 胚胎着床前基因检测
  • 代孕

第七章人类生殖科技市场：依应用分类

  • 保留生育能力
  • 基因检测
  • 不孕症治疗

第八章人类生殖科技市场：依最终使用者分类

  • 不孕不育治疗诊所
  • 医院
  • 研究/学术机构

第九章美洲人类生殖技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区人类生殖技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲人类生殖技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AbbVie Inc.
  • Aurobindo Pharma
  • Bayer AG
  • CooperSurgical Fertility Solutions
  • Eli Lilly and Company
  • European Sperm Bank
  • Evofem Biosciences, Inc.
  • Ferring BV
  • GSK PLC
  • InSEM Fertility Solutions
  • INVO Bioscience
  • KG Medical Industries
  • Mankind Pharma
  • Merck KGaA
  • Microm UK Ltd.
  • Monash IVF Group
  • Pfizer Inc.
  • Pride Angel
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • V Conceive
  • Vitrolab AB
  • Voxtur Bio Ltd.
Product Code: MRR-69324464D214

The Human Reproductive Technologies Market was valued at USD 29.84 billion in 2023, expected to reach USD 31.82 billion in 2024, and is projected to grow at a CAGR of 6.66%, to USD 46.89 billion by 2030.

Human Reproductive Technologies are a diverse set of treatments and technologies aimed at assisting human reproduction through medical and scientific interventions. This scope includes in vitro fertilization (IVF), artificial insemination, fertility drugs, surrogacy, and emerging genomics technologies. The necessity for these technologies is primarily driven by the increasing prevalence of infertility due to delayed childbearing, lifestyle factors, and certain medical conditions. Application-wise, they are extensively utilized in fertility clinics, hospitals, and healthcare research institutions. End-use spans across individual couples desiring children, same-sex couples, and single parents seeking reproductive assistance.

KEY MARKET STATISTICS
Base Year [2023] USD 29.84 billion
Estimated Year [2024] USD 31.82 billion
Forecast Year [2030] USD 46.89 billion
CAGR (%) 6.66%

The market is significantly influenced by the growing awareness and acceptance of reproductive health technologies, advancements in medical sciences, and supportive government regulations for fertility tourism. Moreover, rising disposable income and better healthcare infrastructure in emerging economies drive demand. However, the market faces limitations such as high costs of treatment, ethical and legal concerns, and the potential for psychological stress among patients. Challenges include societal stigmas and varied legal frameworks across different regions impacting technology adoption.

Potential growth opportunities lie in developing affordable and accessible treatment options, personalized medicine adapting reproductive technologies to individual genetic profiles, and advancing technologies such as artificial intelligence to predict treatment outcomes effectively. For businesses looking to capitalize on these opportunities, investment in research and development to create innovative fertility solutions, forming partnerships with healthcare providers for wider service distribution, and advocating for policies that support accessibility and insurance coverage can be strategic steps. Innovation hotspots include non-invasive fertility diagnostics, embryo and gamete cryopreservation, and mobile health applications for patient engagement and education. The market is characterized by rapid technological advancements, increasing competition, and potential collaboration between biotechnology firms, pharmaceuticals, and healthcare sectors to address unmet needs effectively while navigating ethical and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Reproductive Technologies Market

The Human Reproductive Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Changing lifestyles and rising prevalence of infertility and fertility-related disorders
    • Growing medical tourism for specialized fertility treatments
    • Increasing awareness and acceptance of fertility treatments
  • Market Restraints
    • High cost and limited insurance coverage for fertility treatments
  • Market Opportunities
    • Advancements and innovations in human reproductive technology for more effective treatment
    • Patents and copyrights for innovations in the reproductive technologies
  • Market Challenges
    • Limited success rates and associated health risks

Porter's Five Forces: A Strategic Tool for Navigating the Human Reproductive Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Reproductive Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Reproductive Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Reproductive Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Reproductive Technologies Market

A detailed market share analysis in the Human Reproductive Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Reproductive Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Reproductive Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Reproductive Technologies Market

A strategic analysis of the Human Reproductive Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Reproductive Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aurobindo Pharma, Bayer AG, CooperSurgical Fertility Solutions, Eli Lilly and Company, European Sperm Bank, Evofem Biosciences, Inc., Ferring B.V., GSK PLC, InSEM Fertility Solutions, INVO Bioscience, KG Medical Industries, Mankind Pharma, Merck KGaA, Microm UK Ltd., Monash IVF Group, Pfizer Inc., Pride Angel, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., V Conceive, Vitrolab AB, and Voxtur Bio Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Reproductive Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination, Preimplantation Genetic Testing, and Surrogacy.
  • Based on Application, market is studied across Fertility Preservation, Genetic Screening, and Infertility Treatment.
  • Based on End-User, market is studied across Fertility Clinics, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Changing lifestyles and rising prevalence of infertility and fertility-related disorders
      • 5.1.1.2. Growing medical tourism for specialized fertility treatments
      • 5.1.1.3. Increasing awareness and acceptance of fertility treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and limited insurance coverage for fertility treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and innovations in human reproductive technology for more effective treatment
      • 5.1.3.2. Patents and copyrights for innovations in the reproductive technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited success rates and associated health risks
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Reproductive Technologies Market, by Type

  • 6.1. Introduction
  • 6.2. Assisted Reproductive Technology
  • 6.3. In Vitro Fertilizartion
  • 6.4. Intrauterine Insemination
  • 6.5. Preimplantation Genetic Testing
  • 6.6. Surrogacy

7. Human Reproductive Technologies Market, by Application

  • 7.1. Introduction
  • 7.2. Fertility Preservation
  • 7.3. Genetic Screening
  • 7.4. Infertility Treatment

8. Human Reproductive Technologies Market, by End-User

  • 8.1. Introduction
  • 8.2. Fertility Clinics
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Human Reproductive Technologies Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Reproductive Technologies Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Reproductive Technologies Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Aurobindo Pharma
  • 4. Bayer AG
  • 5. CooperSurgical Fertility Solutions
  • 6. Eli Lilly and Company
  • 7. European Sperm Bank
  • 8. Evofem Biosciences, Inc.
  • 9. Ferring B.V.
  • 10. GSK PLC
  • 11. InSEM Fertility Solutions
  • 12. INVO Bioscience
  • 13. KG Medical Industries
  • 14. Mankind Pharma
  • 15. Merck KGaA
  • 16. Microm UK Ltd.
  • 17. Monash IVF Group
  • 18. Pfizer Inc.
  • 19. Pride Angel
  • 20. Sandoz International GmbH
  • 21. Sun Pharmaceutical Industries Ltd.
  • 22. Teva Pharmaceutical Industries Ltd.
  • 23. V Conceive
  • 24. Vitrolab AB
  • 25. Voxtur Bio Ltd.

LIST OF FIGURES

  • FIGURE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZARTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023